Literature DB >> 30072126

Serum Levels of Complement-C1q/Tumor Necrosis Factor-Related Protein-3 Decreased in Patients With Acute Aortic Dissection.

Huimin Jiang1, Menglong Wang1, Jing Ye1, Jianfang Liu1, Zhen Wang1, Yao Xu1, Di Ye1, Jun Wan2.   

Abstract

Complement-C1q/tumor necrosis factor-related protein-3 (CTRP3) is one kind of adipocytokines and has been reported to play key roles in many cardiovascular diseases by regulating inflammation. Inflammation was reported to be involved in the development of acute aortic dissection (AAD). The purpose of this study was to investigate whether serum levels of CTRP3 were associated with AAD. The serum was collected from 108 participants, including 60 patients with AAD and 32 patients with hypertension, as well as 16 healthy subjects. Serum levels of CTRP3, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were measured using enzyme-linked immunosorbent assay kits. Decreased serum levels of CTRP3 were found in AAD patients compared with hypertension and healthy subjects (35.89 ± 11.26 vs 52.60 ± 13.90 and 51.71 ± 18.64 ng/mL, p < 0.001, respectively). IL-6 and TNF-α levels were significantly higher in AAD patients than those in hypertension and healthy subjects (IL-6: 31.33 ± 15.18 vs 13.13 ± 8.63 and 9.40 ± 6.27 pg/mL, p < 0.001; TNF-α: 36.87 ± 11.16 vs 29.66 ± 5.12 and 22.93 ± 7.18 pg/mL, p < 0.001, respectively). In AAD, CTRP3 levels showed a negative correlation with IL-6 and TNF-α levels respectively (r = -0.508, p < 0.001; r = -0.393, p = 0.002, respectively). In conclusion, decreased levels of CTRP3 may be associated with the development of AAD.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30072126     DOI: 10.1016/j.amjcard.2018.06.024

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Complement C1q/Tumor Necrosis Factor-Related Protein-3 (CTRP3) is Significantly Decreased in Patients with Heart Failure and Closely Related with Ventricular Tachycardia.

Authors:  Arafat Yildirim; Hilmi Erdem Sumbul; Hasan Koca; Mehmet Kucukosmanoglu; Yahya Kemal Icen; Mevlut Koc
Journal:  Acta Cardiol Sin       Date:  2021-05       Impact factor: 2.672

Review 2.  New Insights Into Implications of CTRP3 in Obesity, Metabolic Dysfunction, and Cardiovascular Diseases: Potential of Therapeutic Interventions.

Authors:  Bei Guo; Tongtian Zhuang; Feng Xu; Xiao Lin; Fuxingzi Li; Su-Kang Shan; Feng Wu; Jia-Yu Zhong; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Ullah Muhammad Hasnain Ehsan; Ling-Qing Yuan
Journal:  Front Physiol       Date:  2020-12-03       Impact factor: 4.566

3.  Reduced CTRP3 Levels in Patients with Stable Coronary Artery Disease and Related with the Presence of Paroxysmal Atrial Fibrillation.

Authors:  Arafat Yildirim; Mehmet Kucukosmanoglu; Hilmi Erdem Sumbul; Mevlut Koc
Journal:  Arq Bras Cardiol       Date:  2022-01       Impact factor: 2.000

Review 4.  The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin.

Authors:  Han Na Jung; Chang Hee Jung
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.